Preferred Name |
dacarbazine |
|
Synonyms |
Dtic-Dome (TN) 5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide NSC-45388 4-(dimethyltriazeno)imidazole-5-carboxamide DIC dacarbazinum 4-(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide HSDB 3219 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide C6H10N6O dacarbazina 5-(dimethyltriazeno)imidazole-4-carboxamide 5-(3,3-dimethyltriazeno)imidazole-4-carboxamide 5-(dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide Dacarbazine ICDMT dacarbazine 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide NCI-C04717 DTCI Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)- NSC 45388 |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_4305 |
|
AHFScode |
10:00.00 |
|
ATCCode |
L01AX04 |
|
CASRN |
4342-03-4 |
|
DBBrand |
deticene |
|
DBname |
dacarbazine |
|
DBSynonym |
dacarbazinum [inn-latin] dtic-dome imidazole carboxamide dtie dacarbazino [inn-spanish] icdt dtic biocarbazine r icdmt |
|
Definition |
A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma. |
|
has effect |
http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0000376 http://purl.obolibrary.org/obo/OAE_0001509 http://purl.obolibrary.org/obo/OAE_0000415 http://purl.obolibrary.org/obo/OAE_0000319 http://purl.obolibrary.org/obo/OAE_0000021 http://purl.obolibrary.org/obo/OAE_0001448 http://purl.obolibrary.org/obo/OAE_0000660 http://purl.obolibrary.org/obo/OAE_0000197 http://purl.obolibrary.org/obo/OAE_0001025 http://purl.obolibrary.org/obo/OAE_0000600 http://purl.obolibrary.org/obo/OAE_0000920 http://purl.obolibrary.org/obo/OAE_0000608 http://purl.obolibrary.org/obo/OAE_0000601 http://purl.obolibrary.org/obo/OAE_0000375 http://purl.obolibrary.org/obo/OAE_0000551 http://purl.obolibrary.org/obo/OAE_0000943 http://purl.obolibrary.org/obo/OAE_0001295 http://purl.obolibrary.org/obo/OAE_0000584 http://purl.obolibrary.org/obo/OAE_0001129 http://purl.obolibrary.org/obo/OAE_0000034 http://purl.obolibrary.org/obo/OAE_0001205 http://purl.obolibrary.org/obo/OAE_0001217 http://purl.obolibrary.org/obo/OAE_0000396 http://purl.obolibrary.org/obo/OAE_0000390 http://purl.obolibrary.org/obo/OAE_0000362 |
|
has pharmacological target | ||
has role |
http://purl.obolibrary.org/obo/CHEBI_35610 http://purl.obolibrary.org/obo/CHEBI_22333 |
|
InChI |
InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9) |
|
InChIKey |
InChIKey=FDKXTQMXEQVLRF-UHFFFAOYSA-N |
|
inhibits | ||
is metabolised by |
http://purl.obolibrary.org/obo/dinto_2651 |
|
label |
dacarbazine |
|
may interact with | ||
prefixIRI |
obo2:CHEBI_4305 |
|
prefLabel |
dacarbazine |
|
related with | ||
SMILES |
CN(C)N=NC1=C(N=CN1)C(N)=O CN(C)N=Nc1[nH]cnc1C(N)=O |
|
Synonym |
Dtic-Dome (TN) 5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide NSC-45388 4-(dimethyltriazeno)imidazole-5-carboxamide DIC dacarbazinum 4-(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide HSDB 3219 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide C6H10N6O dacarbazina 5-(dimethyltriazeno)imidazole-4-carboxamide 5-(3,3-dimethyltriazeno)imidazole-4-carboxamide 5-(dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide Dacarbazine ICDMT dacarbazine 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide NCI-C04717 DTCI Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno)- NSC 45388 |
|
xref |
National Drug Code Directory:0703-5075-01 Drugs.com:http://www.drugs.com/cdi/dacarbazine.html CASRN:4342-03-4 Wikipedia:Dacarbazine DrugBank:DB00851 CiteXplore:12195827 CiteXplore:10751609 RxList:http://www.rxlist.com/cgi/generic2/dacarbazine.htm Wikipedia:http://en.wikipedia.org/wiki/Dacarbazine Drugs Product Database (DPD):2241445 CiteXplore:23318786 NIST Chemistry WebBook:4342-03-4 CiteXplore:23029050 CiteXplore:11318431 CiteXplore:15010317 PharmGKB:PA449197 CiteXplore:20082117 Reaxys:521487 ChEMBL:1098063 ChEBI:4305 KEGG DRUG:D00288 KEGG COMPOUND:C06936 CiteXplore:21471822 CiteXplore:21654834 Beilstein:521487 |
|
subClassOf |